glutathione kills triple negative cancer GSTP1 Is a Driver of Triple-Negative Breast Cell Metabolism and Pathogenicity Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Frontiers Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens Role of Glutathione in Cancer: From Mechanisms to Therapies Frontiers Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple negative breast cancer Role of Glutathione in Cancer: From Mechanisms to Therapies PMC
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




